SCPHARMACEUTICALS INC. - COMMON STOCK
3.8250
21-May-24 15:59:52
15 minutes delayed
Stocks
-0.2150
-5.32%
Today's range
3.8200 - 4.1188
ISIN
N/A
Source
NASDAQ
-
scPharmaceuticals to Announce First Quarter 2023 Financial Results on Wednesday, May 10, 2023
02 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
22 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
15 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference
23 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection)
21 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Feb 2023 08:00:00 By Nasdaq GlobeNewswire
-
scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
31 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update
30 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
scPharmaceuticals Inc. Announces Appointment of Rachael Nokes as Chief Financial Officer
19 Dec 2022 08:00:00 By Nasdaq GlobeNewswire
-
scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event
14 Dec 2022 08:00:01 By Nasdaq GlobeNewswire
-
scPharmaceuticals Announces Pricing of $50 Million Public Offering
22 Nov 2022 08:01:42 By Nasdaq GlobeNewswire
-
scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock
21 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
scPharmaceuticals Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
09 Nov 2022 16:05:03 By Nasdaq GlobeNewswire
-
scPharmaceuticals to Participate in the Jefferies London Healthcare Conference
02 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
26 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
scPharmaceuticals Announces $100 Million Debt Financing Agreement with Oaktree
10 Oct 2022 08:05:00 By Nasdaq GlobeNewswire
-
30 Sep 2022 08:00:00 By Nasdaq GlobeNewswire
-
scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
01 Sep 2022 08:00:01 By Nasdaq GlobeNewswire